Clinical Trial Update: Penfluridol for Relapsed/Refractory Small Cell Cancers [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update evaluating penfluridol for relapsed or refractory small cell cancers; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Carcinoma of the Cervix
• Small Cell Lung Cancer

Drugs mentioned

• Penfluridol (Penfluridol)

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Small Cell Carcinoma, Small Cell Carcinoma of Lung | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING